🐂 Not all bull runs are created equal. November’s AI picks include 5 stocks up +20% eachUnlock Stocks

Range-bound markets awaits Powell - again

Published 11/09/2023, 12:44 AM
Updated 11/09/2023, 12:45 AM
© Reuters. FILE PHOTO: Federal Reserve Board Chair Jerome Powell answers a question during a press conference following a two-day meeting of the Federal Open Market Committee on interest rate policy in Washington, U.S., November 1, 2023. REUTERS/Kevin Lamarque/File
LLY
-
AZN
-
NVO
-
DTEGY
-

A look at the day ahead in European and global markets from Ankur Banerjee

An uneasy calm prevailed during Asian trade as investors digested a flurry of comments from central bank officials to look for signs of whether global interest rates have peaked, with Fed Chair Jerome Powell yet again to take centre stage.

Powell on Wednesday did not comment on monetary policy in opening remarks at the U.S. central bank statistics conference, but is scheduled to speak at another conference on Thursday with traders ready to scrutinise every word.

At a separate event on Wednesday, European Central Bank chief economist Philip Lane said his bank needs to see further progress in dampening inflationary pressure, and companies along with governments need to chip in to prevent more policy tightening.

U.S. Federal Reserve Bank of Philadelphia President Patrick Harker at yet another event said the Fed's recent decision to hold rates steady was the right choice, and cautioned market participants to not get ahead of themselves.

"A decrease in the policy rate is not something that is likely to happen in the short term," he said.

The ECB's Lane will take the stage again on Thursday while Bank of England Chief Economist Huw Pill will also speak at a another event, with any comments likely to influence the market given a bare economic calendar.

Futures hint at a moderately lower open in European stock markets.

Investors also will keep an eye on shares of Europe's most valuable company, Novo Nordisk (NYSE:NVO), after U.S. and British regulators both gave the thumbs up to Eli Lilly (NYSE:LLY)'s weight-loss treatment Zepbound on Wednesday. The approval paves the way for a powerful rival to blockbuster drug Wegovy in addressing record obesity rates.

In Asia, China's property stocks are back in the spotlight. They rose late on Wednesday after Reuters reported China's State Council had instructed the local government of Guangdong province to help arrange a rescue of Country Garden by Ping An Insurance Group.

Ping An subsequently said in a statement to Reuters it had "not been asked by (the) Government to take over Country Garden".

On Thursday, shares of Ping An extended declines. Country Garden and other property stocks gave up some gains from a day earlier.

Meanwhile, data on Thursday showed China's consumer prices fell and factory-gate deflation persisted in October, indicating pressure on demand has picked up as the world's second-largest economy struggles to emerge from a post-pandemic slump.

Elsewhere, Hollywood actors reached a tentative agreement with major studios on Wednesday to resolve the second of two strikes that have rocked the entertainment industry this year as workers demanded higher pay in the streaming TV era.

Key developments that could influence markets on Thursday:

© Reuters. FILE PHOTO: Federal Reserve Board Chair Jerome Powell answers a question during a press conference following a two-day meeting of the Federal Open Market Committee on interest rate policy in Washington, U.S., November 1, 2023. REUTERS/Kevin Lamarque/File Photo

Earnings: AstraZeneca (NASDAQ:AZN), Merck KGaA, Deutsche Telekom (OTC:DTEGY)

Speakers: ECB chief economist Philip Lane and BOE chief economist Huw Pill in separate events; Fed Chair Powell later in the global day

Latest comments

Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2024 - Fusion Media Limited. All Rights Reserved.